Products

What will AGI do for Anirolac?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9B9E35WUX, chemically known as 1h-pyrrolizine-1-carboxylic acid, 2,3-dihydro-5-(4-methoxybenzoyl)-, (+-)- but generally known as anirolac, which bears US NIH Compound Identifier 47975. European Medicines Agency schedules Anirolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05518MIG. The term ANIROLAC is an International Non-Proprietary Name. ANIROLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule anirolac under HS 29339990 and SITC 51577. As of Q4 2014, ANIROLAC remains the US FDA Preferred Term for this commodity. Anirolac bears US NLM identifiers UMLS ID C0631258 and NCI Concept Code C80536. SMILES: OC(=O)C1CCN2C1CCC2C(=O)C1CCC(OC)CC1.